Barry Callebaut has halted manufacturing operations at its Weize chocolate plant in Belgium as a precautionary measure while conducting its root cause analysis and risk assessment after detecting salmonella in a production lot.
The company identified lecithin as the source of the contamination.
All chocolate products manufactured at the facility since June 25 have been placed on hold.
After the analysis, the lines will be cleaned and sanitized before production can resume.
Barry Callebaut, which informed the Belgian food authorities (FAVV) about the incident, said that their robust food safety programs allowed them to identify lecithin as the source of the contamination quickly.
The company added that they are reaching out to all customers who may have received impacted products.
The news comes after Ferrero temporarily suspended production at its Arlon facility in Belgium after the site was linked to a salmonella outbreak.


Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
Japan Signals Preference for Low Interest Rates as BOJ Policy Debate Intensifies
US Dollar Slips After PCE Inflation Data Eases Fed Rate Hike Expectations
Samsung Electronics Stock Surges on Report of Massive $59 Billion Share Buyback Plan
CDC Confirms U.S. Ebola Case Linked to Congo Outbreak as Travel Restrictions Tighten
Gold Falls Below $4,000 as Strong Dollar and Fed Rate Hike Expectations Weigh on Prices
China Eastern Orders 25 Airbus A330neo Jets in $9.35 Billion Deal to Boost International Expansion
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
Alibaba Shares Fall After Anthropic Alleges Massive AI Model Distillation Campaign
South Korea’s KOSPI Plunges as Apple Price Hikes and OpenAI IPO Delay Shake AI Chip Stocks
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe
Wall Street Ends Lower as AI Stocks Drag Markets, Fed Rate Outlook Shifts
U.S. Dollar Reaches One-Year High as Tech Sell-Off and Fed Rate Hike Expectations Support Demand
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent 



